2024 NAPBC Standards: How MagView Supports New Risk Assessment Requirements

National Accreditation Program for Breast Centers (NAPBC) logo

The 2024 NAPBC Standards are now in effect! These new standards from the National Accreditation Program for Breast Centers (NAPBC) focus on the patient care continuum “from screening and prevention, to diagnosis, treatment, and survivorship,” emphasizing the provision of “value-based care with multidisciplinary support.” Effective January 1, 2024, the new standards require breast centers to […]

Radiologists and Risk Assessment: Employing the Tyrer-Cuzick Score in the Reporting Workflow

"Patient's estimated lifetime risk of breast cancer is 23%"

In the U.S., approximately 1 in 8 women can expect to get breast cancer sometime during their lives. Since early detection is such a critical weapon in the fight against breast cancer, risk assessment is essential to help identify women who can benefit from more intensive breast cancer surveillance. Using breast cancer risk assessment models such as Tyrer-Cuzick in […]

MagView Introduces a Stand-Alone Software for High-Risk Breast Cancer Screening

Luminary Risk is MagView's new stand-alone software for breast cancer risk assessment

Fulton, MD – November 20, 2023 – MagView, a leading healthcare solutions provider, introduces Luminary Risk, an advanced software that enhances high-risk breast screening programs. Recognizing the importance of early detection and personalized care, MagView has launched Luminary Risk, as a dedicated software solution that expands the capabilities of high-risk breast screening programs with advanced […]

How Breast Centers Incorporate Tyrer-Cuzick in Mammogram Reports and Lay Letters

automating mammography reports

Using breast cancer risk assessment models—such as Tyrer-Cuzick—supports risk assessment, which has become best practice in breast screening. This approach helps identify patients who can benefit from personalized screening and helps breast imaging centers drive downstream revenue—such as breast MRI and genetic counseling/testing services. Although there are various models available, the Tyrer-Cuzick v8.0 (IBIS) is […]

Genetic Testing for Breast Cancer: How to Best Incorporate it into Your Imaging Workflow

dna strand

Understanding a patient’s genetics plays an integral role in being able to assess their comprehensive risk for breast cancer. That’s why MagView has incorporated genetic risk factors into its breast cancer risk assessment software and created an easy way for breast centers to integrate genetic testing into their organization’s workflow. The Role of Genetics in […]

Breast Cancer Risk Assessment Software: The Benefits of Integrated Solutions

The importance of breast cancer screening solutions for high-risk patients is demonstrated by statistics that underscore the prevalence of this type of cancer. Breast cancer is currently the most commonly diagnosed cancer in U.S. women and is the second leading cause of cancer death in this demographic. In 2022, breast cancer is expected to account […]

Why Tyrer-Cuzick is the Breast Cancer Risk Model of Choice

women who will develop breast cancer

Personalized breast cancer care is making rapid progress—and breast cancer risk assessment plays an increasingly critical role in support of prevention, early detection, and effective treatment.  There are various breast cancer risk assessment models available, and the Tyrer-Cuzick v8.0 (IBIS) is one of the most reliable tools breast centers can use to identify high-risk patients.  What […]

Request a Demo